Ross Moat - CHIEF COMMERCIAL OFFICER at Kiniksa Pharmaceuticals International, plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
KNSA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Ross Moat - trading volume in the past year for Kiniksa Pharmaceuticals International, plc

Holdings reported by Ross Moat for Kiniksa Pharmaceuticals International, plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Performance Share Unit 5.23K $351K $17.88 May 1, 2025 Direct Class A Ordinary Share
Class A Ordinary Share 9.42K $264K $28.00 May 5, 2025 Direct
Share Option 27.4K May 5, 2025 Direct Class A Ordinary Share
Performance Share Option 8.3K May 1, 2025 Direct Class A Ordinary Share
Restricted Share Unit 2.48K Apr 7, 2025 Direct Class A Ordinary Share

Transactions reported by Ross Moat for Kiniksa Pharmaceuticals International, plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.